CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 77 filers reported holding CULLINAN ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,182,108 | -15.9% | 1,235,592 | +0.0% | 0.07% | -11.1% |
| Q2 2023 | $13,290,418 | +5.1% | 1,235,169 | -0.1% | 0.08% | -2.4% |
| Q1 2023 | $12,647,851 | -3.2% | 1,236,349 | -0.1% | 0.08% | -8.8% |
| Q4 2022 | $13,061,723 | -17.7% | 1,238,078 | -0.0% | 0.09% | -21.6% |
| Q3 2022 | $15,873,000 | +0.0% | 1,238,131 | +0.0% | 0.12% | +8.4% |
| Q2 2022 | $15,867,000 | +22.6% | 1,237,668 | +0.1% | 0.11% | +50.7% |
| Q1 2022 | $12,947,000 | -32.2% | 1,236,560 | -0.1% | 0.07% | -25.3% |
| Q4 2021 | $19,094,000 | -31.7% | 1,237,464 | -0.0% | 0.10% | -36.2% |
| Q3 2021 | $27,939,000 | -11.9% | 1,237,877 | +0.5% | 0.15% | +39.3% |
| Q2 2021 | $31,702,000 | +9837.9% | 1,231,121 | +15993.1% | 0.11% | +10600.0% |
| Q1 2021 | $319,000 | – | 7,650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $78,241,782 | 20.33% |
| CHI Advisors LLC | 3,349,460 | $34,264,977 | 9.10% |
| Nextech Invest Ltd. | 1,221,145 | $12,492,313 | 5.21% |
| BVF INC/IL | 3,196,701 | $32,702,251 | 1.20% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 265,032 | $2,711,277 | 1.12% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $5,115,000 | 0.76% |
| Atom Investors LP | 120,109 | $1,228,715 | 0.67% |
| Boxer Capital, LLC | 1,074,082 | $10,988 | 0.54% |
| SVB FINANCIAL GROUP | 20,274 | $207,403 | 0.40% |
| Parkman Healthcare Partners LLC | 169,886 | $1,737,934 | 0.38% |